NCT07537660 2026-04-17
ADGP
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
Clinical Trials
14 trialsNCT07537673 2026-04-17
ADTD
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07537699 2026-04-17
ADDC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Recruiting
NCT07403370 2026-02-11
Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis
Shandong Cancer Hospital and Institute
Recruiting
NCT06769165 2025-12-11
EMESIS
University Medical Center Groningen
Phase NA Recruiting
NCT03118986 2025-10-08
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy
The Hospital for Sick Children
Phase 2 Recruiting
NCT07038551 2025-07-02
Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study
International University of Health and Welfare
Phase 4 Recruiting
NCT06200168 2025-04-02
Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer
Affiliated Hospital of Qinghai University
Phase 3 Recruiting
NCT06726291 2024-12-10
NOEME
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 4 Recruiting
NCT06588413 2024-11-22
FONDO-LOW
Augusta University
Phase 3 Recruiting
NCT05838638 2024-05-16
Serious Gaming for Chemotherapy-induced Nausea and Vomiting
University of Central Florida
Phase NA Recruiting
NCT06314906 2024-03-21
Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer
Lanzhou University Second Hospital
Phase 3 Recruiting
NCT06017284 2023-11-24
PTCA199-5
Fudan University
Phase 3 Recruiting
NCT05690802 2023-01-19
TSEPHCC
Xijing Hospital
Phase NA Recruiting